Analysis of TCGA glioblastoma data demonstrates that at least 4% (16/434) of tumors harbor explicit co-amplification of EGFR and PDGFRA (Fig. 1a), however a much larger fraction of tumors show co-expression of the corresponding mRNAs at comparable levels (Fig. 1b). Here, EGFR is linked to glioblastoma.